Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Intramuscular Ketamine for Suicidal Patients in the Evanston Hospital Emergency Department for Suicidal Distress
Endeavor Health
Assessing Covert Consciousness During Dexmedetomidine and Ketamine Sedation: An fMRI Study
University of Michigan
Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression
Joshua Rosenblat
The MDK Study: Using a Combination of Methadone-dexmedetomidine-ketamine for Postoperative Pain Control in Patients Undergoing Complex Spine Surgeries.
University of Missouri-Columbia
Psychotherapy Combined With Intranasal Esketamine for the Treatment of Suicidal Ideation
University of California, San Diego
Salivary Oxytocin as a Biomarker of Psychedelic Treatment
University of Geneva, Switzerland
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
Cybin IRL Limited
Ketamine Effects on Learning In Eating Disorders
Amanda Downey, MD
Psilocybin With Intracranial Neural Sensing
Joshua Woolley, MD, PhD
Induction of Dreaming With EEG and Anesthesia in Healthy Adults
Stanford University
High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD
ARQ National Psychotrauma Centre
Assess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric Interventions
Psyrin Inc.
MDMA Plus Exposure Therapy for PTSD
Emory University
Long Term Follow Up KET-PD
Yale University
Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan
Brigham and Women's Hospital
Prediction of REsponse to Depression Interventions Using Clinical and TD-fNIRS Measurements
Kernel
Comparative Analysis of Spinal Anesthesia Versus General Anesthesia for vNOTES
University of Kansas Medical Center
The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training
Felix Mueller
Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)
Medical University of Gdansk
Observational Study of Ketamine Infusions for the Treatment of Chronic Pain
Theresa Lii
Long-term Pain Modulation by Intravenous Esketamine in CRPS
Erasmus Medical Center
Effect of Ketamine and Etomidate During RSI on Long Term Outcomes
Vanderbilt University Medical Center
GA + ESP vs. SA + ESP in Lumbar Decompression Surgeries
Hospital for Special Surgery, New York
Ketamine Infusion for Neuropathic Pain in Brachial Plexus Injuries
Mayo Clinic
Safety and Efficacy of Ketamine Intravenous Infusions in the Treatment of Fibromyalgia
Wilderman Medical Clinic
Psilocybin After Trauma Surgery for Pain
Trent Emerick
Psilocybin for Methamphetamine Use Disorder
Peter Hendricks
Group PACBT for Depression
University of California, Los Angeles
Hemodynamic Responses to Laryngoscopy and Tracheal Intubation
Assiut University
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric Patients (Master Protocol)
Polaryx Therapeutics, Inc.
Electrophysiologic Mechanisms of Ketamine Antidepressant Response
Emory University
MLS101 Study in PMDD
MycoMedica Life Sciences PBC
Psilocybin-Assisted Psychotherapy for Veterans With PTSD
ARQ National Psychotrauma Centre
Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life
Charles Raison
NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
M.D. Anderson Cancer Center
Psilocybin Therapy for Methamphetamine Use Disorder and HIV
Nicky Mehtani, MD, MPH
Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation
Brown University
MDMA-AT for PTSD in Young Adults With Childhood Trauma
Jenna M. Traynor
Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar Depression
Neurocentrx Pharma Pty Ltd
MB-PAT for Demoralization in Advanced Cancer ('PAT-MIND') Trial
University of Calgary
KetAmine and Recovery After Mechanical VentilAtion ( KARMA )
Assistance Publique - Hôpitaux de Paris
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
National Institute on Aging (NIA)
Adaptive Platform Trial for Pain Management in Sickle Cell Vaso-Occlusive Crisis
Assistance Publique - Hôpitaux de Paris
Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal Thoughts
New York State Psychiatric Institute
Oral and Sublingual Ketamine
Western University, Canada
Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder
U.S. Army Medical Research and Development Command
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence
University of Calgary
Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study
Oregon Health and Science University
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.